Copart vs Rentokil Initial
Rentokil Initial is the larger business, with $6.91bn of revenue in fiscal 2025 against $4.67bn for Copart (1.5 times as much). Rentokil Initial grew faster (4.4% against 0.4%). Copart kept more of each dollar of sales as profit: a net margin of 31.8% against 6.8%.
| Latest fiscal year | CopartCPRT, 2026 | Rentokil InitialRTO, 2025 |
|---|---|---|
| Revenue | $4.67bn | $6.91bn |
| Revenue growth | 0.4% | 4.4% |
| Net income | $1.48bn | $470m |
| Operating margin | — | 8.5% |
| Net margin | 31.8% | 6.8% |
| Return on equity | 16.2% | 8.7% |
| Free cash flow | $1.27bn | $764m |
| Cash | $1.91bn | $2.32bn |
| Total debt | $0 | $8.90bn |
| Debt to equity | — | 161.9% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $1.63bn | — |
| Employees | — | — |
| Market value | $28.95bn | $11.99bn |
| Price vs our value range | Within our value range | — |
| Moat score | 90 (Strong) | — |
| Insider trades, 12 months | 0 buys, 8 sales | 0 buys, 0 sales |